Raptor Pharmaceutical Corp. Announces Publication of Results from Phase 2a Trial of DR Cysteamine for Treatment of Cystinosis

Tuesday, January 12, 2010 General News
Email Print This Page Comment bookmark
Font : A-A+

Potential to Improve Treatment with Less Frequent Administration and Better Tolerability

For more information, please contact:

Kim R. Tsuchimoto, CFO

(415) 382-1390

[email protected]

The Ruth Group

Sara Ephraim Pellegrino (investors)

(646) 536-7002

[email protected]

Janine McCargo (media)

(646) 536-7033

[email protected]



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook